Related Experiment Videos
[Cardiopulmonary capacity in patients with coronary heart disease]
U J Winter1, A K Gitt, M Blaum
1Klinik III für Innere Medizin, Universität zu Köln.
Insights
Cardiopulmonary exercise testing (CPX) is a safe and accurate method for assessing exercise capacity in patients with coronary heart disease (CHD). While it doesn't replace traditional diagnostics, CPX provides valuable insights into individual patient responses and may help in risk stratification for CHD.
Area of Science:
- Cardiopulmonary physiology
- Cardiovascular diagnostics
- Exercise medicine
Context:
- Coronary heart disease (CHD) diagnosis and management require accurate assessment of cardiopulmonary exercise capacity.
- Traditional methods for ischemia detection have limitations in quantifying functional capacity and individual patient responses.
- Cardiopulmonary exercise testing (CPX) offers a non-invasive approach to evaluate the integrated response of the heart, lungs, and circulatory system during exercise.
Purpose:
- To investigate the safety, practicability, and accuracy of CPX in patients with invasively documented coronary heart disease (CHD).
- To determine the clinical value of CPX in the diagnosis and assessment of CHD.
- To compare the effectiveness of CPX-derived parameters with existing clinical classifications (CCS, Weber) for describing exercise capacity in CHD patients.
Summary:
- CPX was performed on 101 patients with CHD, demonstrating high safety, accuracy, and day-to-day reproducibility (r > 0.8).
- The respiratory anaerobic threshold was identifiable in 95% of cases using the PET O2 criterion.
- While CPX parameters like anaerobic threshold and maximum VO2 correlate with disease severity and left ventricular function, overlaps exist, limiting precise differentiation. However, CPX effectively captures the ischemic cascade and individual cardiopulmonary responses.
Impact:
- CPX provides secure, practicable, and accurate measurements of individual cardiopulmonary exercise capacity in CHD patients.
- CPX enhances understanding of the complex interactions between muscles, heart, circulation, and lungs during exercise.
- CPX holds potential for future use in identifying CHD patients across low, medium, and high-risk categories, aiding in personalized management strategies.
Abstract:
Cardiopulmonary exercise testing (CPX) allows a non-invasive control of the cardiopulmonary exercise capacity. In this study, we wanted to investigate if the CPX can be securely, practicably, and accurately performed in patients with invasively documented coronary heart disease (CHD). Furthermore, we wanted to find out the clinical value of CPX in CHD diagnosis. The CPX measurements (symptom-limited; ramp program with 20 Watts increase/min; semi-supine position; continuous registration of the cardio-circulatory parameters (HR, RR, ECG), of the gas exchange parameters (O2, CO2) and of the ventilation) in 101 patients have shown that CPX is secure, accurate, and practicable. The day-to-day reproducibility is high (r > 0.8). The respiratory anaerobic threshold can be manually evaluated by means of the PET O2 criterion in 95% of the cases. The CCS-classification of angina pectoris could not accurately describe the cardiopulmonary exercise capacity as compared to the Weber-classification. The disadvantage of the Weber-classification is that it does not respect the age-, sex- and weight-dependent differences of the normal values. Our own data and results from the literature demonstrate that the anaerobic threshold, the maximum VO2 and the maximum O2-pulse are the more reduced the more coronary arteries are involved, the more reduced the left ventricular function is. But, nevertheless, the range of values shows large overlaps so that an exact differentiation, based upon these parameters, is not possible. Patients with similar functional results or degree of reduced exercise capacity have different morphological alterations. Most patients demonstrated typical ischemic cascade with anaerobic threshold, ST-segment alterations, angina pectoris and, finally, reduced max. VO2. In conclusion, CPX does not replace the traditional methods of non-invasive and invasive ischemia detection, but enables secure, practicable, and accurate measurements of the individual cardiopulmonary exercise capacity and the interaction between muscles, heart, circulation, and lungs. Possibly, CPX can be used in the near future for identifying CHD patients with low, medium or high risk.